Key Points - The pole position in the GLP-1 weight loss space is currently held by Eli Lilly. - Novo Nordisk was the early leader, showing that being first doesn't always mean you stay at the head of the pack. - Pfizer's internal candidate flamed out, and it's now making aggressive moves to…
Continue reading...